Trademark Overview
On Wednesday, September 13, 2006, a trademark application was filed for ADPRIAV with the United States Patent and Trademark Office. The USPTO has given the ADPRIAV trademark a serial number of 78973523. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, November 2, 2007. This trademark is owned by Eli Lilly and Company. The ADPRIAV trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes; antipsychotic agents; and antidepressants
